Cited by 52Dementia and Cognitive Impairment ResearchHerpesvirus Infections and TreatmentsPharmaceutical Practices and Patient Outcomes

Antiherpetic medication and incident dementia: Observational cohort studies in four countries

Open access
Schnier, Christian, Janbek, Janet, Williams, Linda, Wilkinson, Tim, Laursen, Thomas M., Waldemar, Gunhild, Richter, Hartmut, Kostev, Karel +2 more·2021·European Journal of Neurology

Published version of a preprint

Abstract

Background and purpose: Several epidemiological studies from Taiwan, all using the same data resource, found significant associations between herpes virus infection, antiherpetic medication, and subsequent dementia. We conducted a multicenter observational cohort study using health registry data from Wales, Germany, Scotland, and Denmark to investigate potential associations between antiherpetic medication and incident dementia, and also to comprehensively investigate such associations broken down according to medication type and dose, type of herpes virus, and dementia subtype. Methods: A total of 2.5 million individuals aged 65 years or more were followed up using linked electronic health records in four national observational cohort studies. Exposure and outcome were classified using coded data from primary and secondary care. Data were analyzed using survival analysis with time‐dependent covariates. Results: Results were heterogeneous, with a tendency toward decreased dementia risk in individuals exposed to antiherpetic medication. Associations were not affected by treatment number, herpes subtype, dementia subtype, or specific medication. In one cohort, individuals diagnosed with herpes but not exposed to antiherpetic medication were at higher dementia risk. Conclusions: Short‐term antiherpetic medication is not markedly associated with incident dementia. Because neither dementia subtype nor herpes subtype modified the association, the small but significant decrease in dementia incidence with antiherpetic administration may reflect confounding and misclassification.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ene.14795

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies using electronic health records have found a link between VZV and risk of all-cause dementia, AD, vascular dementia, with antivirals decreasing all-cause dementia risk.

    “Studies using electronic health records have found a link between VZV and risk of all-cause dementia, AD, vascular dementia, with antivirals decreasing all-cause dementia risk [23,36–40].”

    From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [38]

    The Introduction reports studies linking VZV infection to incident dementia, and the Dementia incidence results find a small association between antiherpetic medication and lower dementia incidence in some cohorts. The paper does not establish a VZV-specific link to Alzheimer disease or vascular dementia: its findings for those subtypes concern medication exposure, not VZV infection. It also cautions in the Discussion that the medication association was heterogeneous and may reflect confounding, rather than a demonstrated reduction caused by antivirals. Page numbers were not provided in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 18

  1. Abbott A. Are infections seeding some cases of Alzheimer's dis- ease? Nature. 2020;587(7832):22-25.
  2. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ϵ4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43(8):1467-1472.
  3. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet. 1997;349(9047):241-244.
  4. Powell-Doherty RD, Abbott ARN, Nelson LA, Bertke AS. Amyloid-β and p-Tau anti-threat response to herpes simplex virus 1 infection in primary adult murine hippocampal neurons. J Virol. 2020;94(9): e01874-19.
  5. Bubak AN, Beseler C, Como CN, et al. Amylin, Aβ42, and amyloid in varicella zoster virus vasculopathy cerebrospinal fluid and infected vascular cells. J Infect Dis. 2020. https://doi.org/10.1093/infdi s/ jiaa513. · DOI
  6. Tsai MC, Cheng WL, Sheu JJ, et al. Increased risk of dementia follow- ing herpes zoster ophthalmicus. PLoS One. 2017;12(11):e0188490.
  7. Bae S, Yun S-C, Kim M-C, et al. Association of herpes zoster with de- mentia and effect of antiviral therapy on dementia: a population-based cohort study. European Archives of Psychiatry and Clinical Neuroscience. 2020;http://dx.doi.org/10.1007/s0040 6-020-01157 -4. · DOI · Paper page
  8. Warren-Gash C, Forbes HJ, Williamson E, et al. Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis. Sci Rep. 2019;9(1):4743.
  9. Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K. Basic characteristics and representativeness of the German Disease Analyzer database. Int J Clin Pharmacol Ther. 2018;56(10):459-466.
  10. Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(7):22-25.
  11. Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449-490.
  12. Wallach Kildemoes H, Toft Sørensen H, Hallas J. The Danish na- tional prescription registry. Scand J Public Health. 2011;39(7):38-41.
  13. Hagger-Johnson G. Opportunities for longitudinal data linkage in Scotland. Scott Med J. 2016;61(3):136-145.
  14. Wilkinson T, Schnier C, Bush K, et al. Identifying dementia out- comes in UK Biobank: a validation study of primary care, hospital admissions and mortality data. Eur J Epidemiol. 2019;34(6):557-565.
  15. Friedman M. Piecewise exponential models for survival data with covariates. Ann Stat. 1982;10(1):101-113.
  16. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribu- tion in the world. Is APOE * 4 a 'thrifty' allele? Ann Hum Genet. 1999;63(4):301-310.
  17. Pincus T, Callahan LF. What explains the association between so- cioeconomic status and health: primarily access to medical care or mind-body variables? Advances. 1995;11(1):4-36.
  18. Wilkinson T, Schnier C, Bush K, Hutchison A, Rannikmäe K, Sudlow C. P1-559: drug prescriptions and dementia incidence: a medication-wide association study. Alzheimer's Dement. 2019;15:P488-P489.

Cited by

Sorted by citations

Authors
Schnier, C., Janbek, J., Williams, L., Wilkinson, T., Laursen, T. M., Waldemar, G., Richter, H., Kostev, K., Lathe, R., & G Haas, J.
Affiliations
  • University of Edinburgh (GB)
  • University of Copenhagen (DK)
  • Aarhus University (DK)
  • IQVIA (United Kingdom) (GB)
  • Division of Infection Medicine University of Edinburgh Edinburgh United Kingdom
Corresponding author
Schnier, Christian
Venue
European Journal of Neurology
Publisher
Wiley
Published
2021-03-19
Volume
28
Issue
6
Pages
1840-1848
ISSN
  • 1351-5101 (ISSN-L)
  • 1468-1331
OpenAlex
W3134069256
Cited by
52
References
4
Citations by year
2026: 9 · 2025: 6 · 2024: 16 · 2023: 6 · 2022: 10 · 2021: 5
FWCI
6.58
Type
journal article
Language
en
Open access
Locations
  • European Journal of Neurology (publishedVersion, cc-by-nc)
  • medRxiv (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
Funders
  • Benter Foundation
  • Medical Research Council (MR/P011349/1)
  • Biotechnology and Biological Sciences Research Council (BB/K003801/1)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Epidemiology › Herpesvirus Infections and Treatments
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
dementia, herpesvirus infection, herpes simplex virus, antiviral agents, dementia risk, dementia subtypes, confounding, misclassification, older adults
MeSH terms
Dementia, Herpesviridae Infections, Humans, Registries, Risk Factors, Cohort Studies, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review